The effect of a multispecies probiotic on the composition of the faecal microbiota and bowel habits in chronic obstructive pulmonary disease patients treated with antibiotics

British Journal of Nutrition

Volumn 103, Issue 10, 2010, Pages 1452-1460

  Koning, Catherina J M ^a   Jonkers, Daisy ^a   Smidt, Hauke ^b   Rombouts, Frans ^b,c   Pennings, Herman Jan ^d   Wouters, Emiel ^a,d   Stobberingh, Ellen ^a   Stockbrügger, Reinhold ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c WINCLOVE PROBIOTICS   (Netherlands)

^d Center for Integrated Rehabilitation of Organ Failure   (Netherlands)

Author keywords

Antibiotics; Bowel movements; Intestinal microbiota; PCR denaturing gradient gel electrophoresis; Probiotics

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; DOXYCYCLINE; ECOLOGIC; PLACEBO; PROBIOTIC AGENT; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ENDOTOXIN;

ABSENCE OF SIDE EFFECTS; ADULT; AEROBIC BACTERIUM; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTEROIDES; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM LONGUM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFECATION; DEFECATION HABIT; DENATURING GRADIENT GEL ELECTROPHORESIS; DIARRHEA; DOUBLE BLIND PROCEDURE; ENTEROBACTERIACEAE; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FECES ANALYSIS; FECES MICROFLORA; FEMALE; HUMAN; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS SALIVARIUS; MALE; MINIMUM INHIBITORY CONCENTRATION; PATIENT COMPLIANCE; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; TREATMENT DURATION; BACTERIUM; CHEMISTRY; DRUG EFFECT; FECES; FUNGUS; ISOLATION AND PURIFICATION; MICROBIOLOGY; PH;

BACTERIA (MICROORGANISMS);

ANTI-BACTERIAL AGENTS; BACTERIA; DEFECATION; DOUBLE-BLIND METHOD; ENDOTOXINS; FECES; FUNGI; HUMANS; HYDROGEN-ION CONCENTRATION; PROBIOTICS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 77953074763     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114509993497     Document Type: Article

References (55)

1. Rajilic-Stojanovic M, Smidt H & de Vos WM (2007) Diversity of the human gastrointestinal tract microbiota revisited. Environ Microbiol 9, 2125-2136. (Pubitemid 47222128)
2. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. (2008) A core gut microbiome in obese and lean twins. Nature 457, 480-484.
3. Zoetendal EG, Vaughan EE & de Vos WM (2006) A microbial world within us. Mol Microbiol 59, 1639-1650.
4. Maukonen J, Matto J, Satokari R, et al. (2006) PCR DGGE and RT-PCR DGGE show diversity and short-term temporal stability in the Clostridium coccoides-Eubacterium rectale group in the human intestinal microbiota. FEMS Microbiol Ecol 58, 517-528.
5. Vanhoutte T, Huys G, De brandt E, et al. (2004) Temporal stability analysis of the microbiota in human feces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers. FEMS Microbiol Ecol 48, 437-446.
6. Zoetendal EG, Akkermans AD & De Vos WM (1998) Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 64, 3854-3859.
7. Zoetendal EG, Rajilic-Stojanovic M & de Vos WM (2008) High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57, 1605-1615.
8. Dethlefsen L, Huse S, Sogin ML, et al. (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6, e280.
9. Jernberg C, Lofmark S, Edlund C, et al. (2007) Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 1, 56-66.
10. Koning CJM, Jonkers DMAE, Stobberingh EE, et al. (2005) Effect of a multispecies probiotic on the composition of the dominant faecal flora in healthy volunteers. Gut 54, Suppl. VII, A234.
11. Barnes PJ (2000) Mechanisms in COPD: differences from asthma. Chest 117, 10S-14S.
12. Turato G, Zuin R & Saetta M (2001) Pathogenesis and pathology of COPD. Respiration 68, 117-128.
13. Burge S & Wedzicha JA (2003) COPD exacerbations: definitions and classifications. Eur Respir J Suppl 41, 46s-53s.
14. Donaldson GC, Seemungal TA, Patel IS, et al. (2003) Longitudinal changes in the nature, severity and frequency of COPD exacerbations. Eur Respir J 22, 931-936.
15. Cebra JJ (1999) Influences of microbiota on intestinal immune system development. Am J Clin Nutr 69, 1046S-1051S.
16. Hogenauer C, Hammer HF, Krejs GJ, et al. (1998) Mechanisms and management of antibiotic-associated diarrhea. Clin Infect Dis 27, 702-710.
17. Macpherson AJ & Uhr T (2004) Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303, 1662-1665.
18. Noverr MC & Huffnagle GB (2004) Does the microbiota regulate immune responses outside the gut? Trends Microbiol 12, 562-568.
19. Cremonini F, Di Caro S, Nista EC, et al. (2002) Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther 16, 1461-1467.
20. D'Souza AL, Rajkumar C, Cooke J, et al. (2002) Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 324, 1361.
21. Hickson M, D'Souza AL, Muthu N, et al. (2007) Use of pro-biotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 335, 80.
22. McFarland LV (2006) Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 101, 812-822.
23. Timmerman HM, Niers LE, Ridwan BU, et al. (2007) Design of a multispecies probiotic mixture to prevent infectious complications in critically ill patients. Clin Nutr 26, 450-459.
24. Anthonisen NR, Manfreda J, Warren CP, et al. (1987) Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 106, 196-204.
25. van der Molen T, Willemse BW, Schokker S, et al. (2003) Development, validity and responsiveness of the clinical COPD questionnaire. Health Qual Life Outcomes 1, 13.
26. O'Donnell LJ, Virjee J & Heaton KW (1990) Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate. BMJ 300, 439-440.
27. Nubel U, Engelen B, Felske A, et al. (1996) Sequence heterogeneities of genes encoding 16S rRNAs in Paenibacillus polymyxa detected by temperature gradient gel electrophoresis. J Bacteriol 178, 5636-5643.
28. Sousa DZ, Pereira MA, Stams AJ, et al. (2007) Microbial communities involved in anaerobic degradation of unsaturated or saturated long-chain fatty acids. Appl Environ Microbiol 73, 1054-1064.
29. Muyzer G, de Waal EC & Uitterlinden AG (1993) Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl Environ Microbiol 59, 695-700.
30. Sanguinetti CJ, Dias Neto E & Simpson AJ (1994) Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques 17, 914-921.
31. Konstantinov SR, Zhu W-Y, Williams BA, et al. (2003) Effect of fermentable carbohydrates on faecal bacterial communities as revealed by DGGE analysis of 16S rDNA. FEMS Microbiol Ecol 43, 225-235.
32. Possemiers S, Verthe K, Uyttendaele S, et al. (2004) PCR-DGGE-based quantification of stability of the microbial community in a stimulator of the human intestinal microbial ecosystem. FEMS Microbiol Ecol 49, 495-507.
33. Suzuki MT, Taylor LT & DeLong EF (2000) Quantitative analysis of small-subunit rRNA genes in mixed microbial populations via 5-nuclease assays. Appl Environ Microbiol 66, 4605-4614.
34. Byun R, Nadkarni MA, Chhour KL, et al. (2004) Quantitative analysis of diverse Lactobacillus species present in advanced dental caries. J Clin Microbiol 42, 3128-3136.
35. Satokari RM, Vaughan EE, Akkermans AD, et al. (2001) Bifidobacterial diversity in human feces detected by genus-specific PCR and denaturing gradient gel electrophoresis. Appl Environ Microbiol 67, 504-513.
36. Fuentes S, Egert M, Jimenez-Valera M, et al. (2008) A strain of Lactobacillus plantarum affects segmented filamentous bacteria in the intestine of immunosuppressed mice. FEMS Microbiol Ecol 63, 65-72.
37. Koning CJ, Jonkers DM, Stobberingh EE, et al. (2007) The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin. Am J Gastroenterol 102, 1-12.
38. Hartemink R, Domenech VR & Rombouts FM (1997) LAMVAB-a new selective medium for the isolation of lactobacilli from faeces. J Microbiol Methods 29, 77-84.
39. Bruinsma N, Hutchinson JM, van den Bogaard AE, et al. (2003) Influence of population density on antibiotic resistance. J Antimicrob Chemother 51, 385-390.
40. Nys S, Okeke IN, Kariuki S, et al. (2004) Antibiotic resistance of faecal Escherichia coli from healthy volunteers from eight developing countries. J Antimicrob Chemother 54, 952-955.
41. De La Cochetiere MF, Durand T, Lepage P, et al. (2005) Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J Clin Microbiol 43, 5588-5592.
42. Sullivan A, Edlund C & Nord CE (2001) Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 1, 101-114.
43. Woodmansey EJ (2007) Intestinal bacteria and ageing. J Appl Microbiol 102, 1178-1186.
44. Goris H, de Boer F & van der Waaij D (1988) Kinetics of endotoxin release by gram-negative bacteria in the intestinal tract of mice during oral administration of bacitracin and during in vitro growth. Scand J Infect Dis 20, 213-219.
45. Holzheimer RG (2001) Antibiotic induced endotoxin release and clinical sepsis: a review. J Chemother 13, Spec No. 1, 159-172.
46. Hurley JC (1995) Endotoxemia: methods of detection and clinical correlates. Clin Microbiol Rev 8, 268-292.
47. Hurley JC (1995) Antibiotic-induced release of endotoxin. A therapeutic paradox. Drug Saf 12, 183-195.
48. Ammor MS, Florez AB & Mayo B (2007) Antibiotic resistance in non-enterococcal lactic acid bacteria and bifidobacteria. Food Microbiol 24, 559-570.
49. Brismar B, Edlund C & Nord CE (1993) Impact of cefpodoxime proxetil and amoxicillin on the normal oral and intestinal microflora. Eur J Clin Microbiol Infect Dis 12, 714-719.
50. Lode H, Von der Hoh N, Ziege S, et al. (2001) Ecological effects of linezolid versus amoxicillin/clavulanic acid on the normal intestinal microflora. Scand J Infect Dis 33, 899-903.
51. Woodmansey EJ, McMurdo ME, Macfarlane GT, et al. (2004) Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol 70, 6113-6122.
52. Goossens D, Jonkers D, Russel M, et al. (2003) The effect of Lactobacillus plantarum 299v on the bacterial composition and metabolic activity in faeces of healthy volunteers: a placebo-controlled study on the onset and duration of effects. Aliment Pharmacol Ther 18, 495-505.
53. Lund B, Edlund C, Barkholt L, et al. (2000) Impact on human intestinal microflora of an Enterococcus faecium probiotic and vancomycin. Scand J Infect Dis 32, 627-632.
54. Tannock GW, Munro K, Harmsen HJ, et al. (2000) Analysis of the fecal microflora of human subjects consuming a pro-biotic product containing Lactobacillus rhamnosus DR20. Appl Environ Microbiol 66, 2578-2588.
55. Kajander K, Myllyluoma E, Rajilic-Stojanovic M, et al. (2007) Clinical trial: multispecies probiotic supplementation alleviates the symptoms of IBS and stabilises intestinal microbiota. Aliment Pharmacol Ther 27, 48-57.